In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational ...

What an amazing year 2024 was in terms of advances in cardiovascular care! With more than 882,000 users, ACC.org continues to be a critical resource for cardiovascular clinicians around the world! The ...

A unique blend of forum and network, the Cardiovascular (CV) Team Member Section and Leadership Council is advancing ACC's efforts to identify and address gaps in areas of professional importance to ...

Submissions for the CV Team and CV Pharmacists Poster Sessions at ACC.25, taking place March 29-31, 2025, in Chicago, IL, are now open. All members of the cardiovascular team are invited to submit ...

Time is running out to showcase your expertise! JACC: Case Reports is seeking standout cases that highlight the critical role of multi-modality imaging in the diagnosis or intervention of complex ...

There's still time to join your colleagues at the Valentin Fuster Cardiovascular Symposium, taking place Dec. 6-8 in Washington, DC. Explore sessions like: Evolving Strategies of Antithrombotic ...

There are several companies that are not affiliated with the American College of Cardiology that are posting registration and housing information for ACC.24. To protect your information, please only ...

In this week’s View, Dr. Eagle looks at the 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. He then discusses sex differences in ...

In this week’s View, Dr. Eagle looks at the use of waist-high compression tights in patients with postural orthostatic tachycardia syndrome (POTS). He then discusses a consensus statement on platelet ...

Highlighted text has been updated as of December 20, 2024. The SURMOUNT-1 trial showed that among patients with obesity, once-weekly tirzepatide reduced body weight substantially as compared to ...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane debate and discuss the outcomes of the trials presented on day 2 at ACC.24 including REDUCE-AMI (0:35), DanGer-Shock (3:28), ...

Drs. Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane debate and discuss the outcomes of the trials presented on day 3 at ACC.24 including TARGET BP I (0:39), DEDICATE DZHK6 (3:07) and FULL ...